2 completed, 1 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Active not recruiting 1 |
Follow Caredx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients Reduction in antimetabolite immunosuppression - COVID-19, Immunosuppression | Phase 4 | Active not recruiting | University of California, Davis | 14 | 2021-09-24 | 2026-04-03 |
| Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression Belatacept - Kidney Transplant Immunosuppression | Phase 4 | Completed | University of Texas Southwestern Medical Center | 25 | 2021-07-28 | 2026-08-14 |
| Immune Monitoring to Facilitate Belatacept Monotherapy Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression | Phase 4 | Completed | Massachusetts General Hospital | 17 | 2020-02-11 | 2023-12-04 |
COVID-19 (1)
Abatacept (2) · Everolimus (1) · Mycophenolic Acid (1) · Prednisone (1) · Sirolimus (1)
United States (3)
Cyrus Feizpour, MD (1) · David Wojciechowski, DO (1) · Hannah Gilligan, MD (1)